European Comission has recently published Regulations regarding approvals of two active substances:
- Chrysanthemum cinerariaefolium, extract (CAS: 89997-63-7, EC: 289-699-3) – both types based on extraction method have been approved; for PT 19
- Didecyldimethylammonium chloride (CAS: 7173-51-5, EC: 230-525-2); for PT 1 and PT 2
I wrote about this earlier this year, after the adoption of positive opinions for approval by the Biocidal Products Committee (BPC)
Now we have an official publication and the date of approval for these active substances. This date is 1.2.2024.
What does this mean for your biocidal products?
If your products have already been notified and are published in biocidal products registers of your market countries, you need to prepare for the product authorization. Applications for authorizations must be submitted on 31.1.2024 at the latest.
If your products are not yet on the market and are also not notified, you can choose this procedure only until 31.1.2024 (in few countries even a couple of months earlier). At the same time, you also need to submit an application for authorization by that date.
Only biocidal products that have been notified and where the authorization application has been submitted by 31.1.2024 may stay on the market during the authorization assessment phase (which takes a few years).
This date may seem far away, but I can tell you from experience how challenging it can be to prepare an authorization application and missing the deadline means that your products will not be allowed to enter the market for at least a couple of years.
If you want us to prepare the best strategy for your biocidal products to stay on the market without worries, give us a call.